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Abstract
Background: The allergenicity of Ricinus communis L. (castor bean, Euphorbiaceae) is associated with components of its
seeds and pollen. Castor bean allergy has been described not only in laboratory workers, but also in personnel working in oil
processing mills, fertilizer retail, the upholstery industry and other industrial fields. In the present study, we describe the
critical amino acids in the IgE-binding epitopes in Ric c 1 and Ric c 3, two major allergens of R. communis. In addition, we
also investigate the cross-reactivity between castor bean and some air and food allergen extracts commonly used in allergy
diagnosis.
Methodology/Principal Findings: The IgE reactivity of human sera from atopic patients was screened by immune-dot blot
against castor bean allergens. Allergenic activity was evaluated in vitro using a rat mast cell activation assay and by ELISA.
Cross-reactivity was observed between castor bean allergens and extracts from shrimp, fish, gluten, wheat, soybean, peanut,
corn, house dust, tobacco and airborne fungal allergens. We observed that treatment of rat and human sera (from atopic
patients) with glutamic acid reduced the IgE-epitope interaction.
Conclusions/Significance: The identification of glutamic acid residues with critical roles in IgE-binding to Ric c 3 and Ric c 1
support the potential use of free amino acids in allergy treatment.
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Introduction
Castor bean (Ricinus communis L.) contains approximately 50% oil,
which has special characteristics such as a high viscosity, a high
stability under heat and pressure, a low freezing point, and the ability
to form waxy substances upon chemical treatment. As 0energy
demands increase and fossil fuels are limited, the development of
alternative renewable fuels becomes imperative. Interest in biodiesel
has been increasing owing to its environmental benefits and
renewability [1–3]. As castor beans are a good biofuel source [3],
castor bean cultivationislikely to increase, posing arisk of exposure to
pollen allergens [4–6]. In previous studies, major castor bean
allergens were identified [7–11]. We have recently reported the
identification of IgE-binding epitopes of castor bean seed allergens,
defining four continuous epitopes in Ric c 3 and two in Ric c 1 [12].
In the present study we identify critical amino acids for IgE
binding and investigate cross-reactivity with allergens typically
used for allergy diagnosis. Initially, we utilized the glutamic acid-
specific Woodward’s Reagent K, WRK, (N-ethyl-5-phenylisox-
azolium-39-sulfonate) [13] to demonstrate the importance of the
glutamic acid carboxylic group in the Ric c 1 and Ric c 3 epitopes
in IgE binding. In addition, pre-incubation of atopic patient serum
with free amino acids (glutamic acid) blocked IgE epitope
interaction sites. We also have observed cross-reactivity between
castor bean and airborne and food allergens, which was also
reduced by incubation with dicarboxylic amino acids.
Methods
Plant material and 2S albumin purification
Castor bean (R. communis L., cultivar IAC-226) seeds were
obtained from the Instituto Agrono ˆmico de Campinas, Sa ˜o Paulo/
Brazil. The 2S albumin fractions were isolated and characterized
by SDS-PAGE and immunoblotting experiments as described
previously [9]. The 2S albumin isoforms, Ric c 1 and Ric c 3 as
well as their polypeptide chains were isolated as described by [12].
Animals and antiserum
Isogenic female R/A Tor rats, generally high producers of IgE,
were obtained from the animal facility of the Universidade Federal
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were approved by the animal research ethics committee of this
University (Proc. CEUA-UENF/112). Immunizations with the 2S
albumin pool (Ric c 1 plus Ric c 3) and serum separation were
conducted as previously described [12].
Extraction of IgG by affinity chromatography
IgG and IgE from human and rat sera were separated by
affinity chromatography using protein G-Sepharose beads in batch
mode with 1.5 mL polypropylene tubes (Sigma protocols). Thirty
micro litres of total serum of immunized R/A Tor rat was mixed
with the 100 mL of resin and with 50 mL of equilibration buffer.
This mixture was incubated for 16 hours under stirring at 4uC.
The mixture was centrifuged and the supernatant denoted FE
(fraction likely enriched in IgE) was removed and stored at 4uC.
After removal of the supernatant, the resin was washed ten times
with 100 mL of equilibration buffer to remove the remaining
uncoupled material. The immunoglobulin coupled to protein G-
Sepharose was eluted using 100 mL of a 0.5 M acetic acid. The
acidic solution was immediately neutralized by the addition of 1 M
Tris-HCl pH 9.0. After washing and centrifugation, the eluted
fraction, denoted FG (fraction likely enriched in IgG), was isolated.
The presence of IgG was investigated in both FE and FG by dot
blotting. Mast cell degranulation assays in the presence of FG or
FE were also performed to identify the immunoglobulin involved
in mast cell activation.
Affinity Dot Blotting
Human serum analysis: sera from five patients who had total
IgE values of 106 to 1527 KU/L were evaluated for their ability to
recognize 2S albumin from R. communis by dot blotting. After the
first evaluation, patient serum with high intensity recognition of
castor bean allergens was used in subsequent assays.
For dot blot assays, 2S albumin or synthetic peptide (10 mgi n
10 mL/dot) was spotted onto a nitrocellulose membrane and
allowed to dry. The nitrocellulose membrane was incubated with
total serum (1:50) or affinity supernatant or eluted fractions, FE
and FG, from human or rat serum. Secondary anti-rat IgG or
anti-human biotin IgE (0.5 mg/mL) (both diluted 1:2000) was
then added to the membrane for 1 hour. Two hours later, IgG was
detected using a rabbit anti-rat IgG- HRP conjugate (1:2500). For
IgE detection, the membrane was subsequently incubated with
streptavidin-biotinylated HRP complex for 1 h. The colour of all
probes was developed with a substrate mixture: 5 mg of DAB in
4.9 mL of water, 300 mL of 0.1 M imidazole, 100 mL of Tris-HCl
2 M buffer (pH 7.5) and 5 mL of 30% H2O2.
Rat peritoneal mast cells
Wistar rats were obtained from the animal facility of the
Universidade Estadual do Norte Fluminense Darcy Ribeiro
(UENF). All experimental procedures were approved by the
animal research ethics board of the UENF (Proc. CEUA-UENF/
112). Rats (weighing ,250 g) were euthanized with CO2 and a
peritoneal wash was performed by injection of 20 mL of DMEM
(Dulbecco’s Modified Eagle Medium) containing 12 U/mL of
heparin. The abdomen was gently massaged for approximately
90 s. The peritoneal cavity was carefully opened and the fluid
containing peritoneal cells was aspirated with a Pasteur pipette.
Thereafter, the cells were transferred to Petri plates and incubated
for 30 min at 37uC. Two-thirds of the supernatant was aspirated
and discarded. The mast cell-rich supernatant (1.8610
5 mast
cells/mL) was separated into 100 mL aliquots and kept at room
temperature.
Mast cell degranulation assays and cross-reactivity
Rat peritoneal mast cells (100 mL) were incubated with pre-
immune serum (control) and activated for 60 min at 37uC using 2S
albumin polyclonal anti-rat IgE (2S alb AR IgE). After
sensitization with 2S alb AR IgE, cells were washed twice with
DMEM. Each experiment was carried out in the presence or
absence of the synthetic peptides and a 2S albumin pool (100 ng).
After incubation with antibodies and potential allergens (synthetic
peptides, 2S albumin), histamine contents were determined (see
below) and the cells (in 10 mL) were stained for 15 min with 10 mL
of a solution containing 0.1% toluidine blue, 10% formaldehyde
and 1% acetic acid, pH 2.8, allowing the visualization of
degranulated mast cells. Granulated and degranulated mast cells
were counted under a light microscope using the 40 X objective in
a Neubauer chamber.
In order to investigate cross-reactivity between 2S albumin from
R. communis and allergens used for allergy diagnosis, mast cells
previously sensitized by 2S alb AR IgE were incubated with
airborne and food allergens from FDA Allergenic (FDA-PRICKIT-
Lot 04AK00001 and FDA-FOODKIT lot 04AK00004).
The airborne allergens that were tested were from dust,
airborne fungi, wool, dust mites, grass, flowers, tobacco, cat
epithelium, dog epithelium, horse epithelium, bovine epithelium,
epithelia mix, feathers, cotton, horsehair, grass, chamomile,
cockroaches, pyrethrum, silk, and cattails. The food allergens
were from poultry, shrimp, beef, pork, egg, egg yolk, milk, fish,
rice, gluten, corn, wheat, soybean, pepper, pineapple, cocoa,
cashew, peanuts, orange, lemon, tomato and strawberry. Protein
content measurements of the allergen solutions from FDA
allergenic were performed using the Bradford method using egg
albumin as a standard. Stock solutions containing 10 mg/mL were
prepared and each test used 10 mL of these allergen solutions.
Mast cell activation was evaluated by taking the percentage of
granulated and degranulated cells as described previously and by
the quantification of histamine released.
Histamine quantification
After incubation with antibodies and allergens, the cell
suspensions (100 mL) were centrifuged at 170 xg for 10 min. An
aliquot of the supernatant (20 mL) was removed for histamine
detection. The released histamine was submitted to ion exchange
chromatography and quantified using a previously described
protocol [12].
Identification of amino acids involved in IgE binding.
The peptides previously identified as IgE-binding epitopes in
Ric c 1 or Ric c 3 allergens by Felix et al. [12] were synthesized
utilizing the solid phase method. The synthetic peptide sequences
are displayed in Table 1. All six peptides (P0 to P5) contained two
or more dicarboxylic amino acid residues. In order to investigate
which amino acid was able to bind to sensitized mast cells, two
strategies were employed: chemical modification of synthetic
peptides using Woodward’s Reagent K (WRK) and treatment of
IgE-mast cells with free amino acids as a potential IgE blocker.
Modification with Woodward’s Reagent K (WRK)
WRK is a specific reagent for modifying dicarboxylic amino
acids [3]. Samples (500 mg of peptides or 1000 mg of the "pool" of
2S albumin) were treated with the WRK solution (250 mM in
0.001 M HCl). Fifty micro litres of samples and 50 mL of WRK
solution were kept at 35uC for 3 hours. Peptide re-purification and
chemical modification were evaluated by reverse-phase HPLC and
mass spectrometry. The allergenicity of treated peptides or 2S
Critical Amino Acids in IgE-Binding
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described above.
Evaluation of chemical modifications using reverse-phase
high performance liquid chromatography
To verify the modifications on the proteins after chemical
treatments, the samples, synthetic peptides and 2S albumin were
subjected to reverse-phase liquid chromatography on a C18
column (Sephasil peptide C18 5 mST 4.6/250, flow rate of 0.7 mL
min
21 using 0.1% trifluoroacetic acid (TFA) as solvent A and 80%
of acetonitrile containing 0.1% TFA as solvent B.) using a
Shimadzu apparatus. The elution profile was monitored by on-line
measurement of the absorbance at 220 nm. Fractions containing
the major peaks were dried in a speed Vac system. The UV
spectrum was obtained using a photo-diode detector.
Blockage of IgE
Mast cells sensitized with IgE were treated with 100 ng of
aspartic acid, glutamic acid or a mixture containing 100 ng of
each other amino acids present in the synthetic peptide (Gly, Leu,
Arg, Gln, Ala, Ile, Ser for P0; Ser, Lys, Gly, Arg, Gln, Cys for P1;
Gln, Val, Arg, Lys, Leu, Ser, Cys, Tyr, for P2; Gln, Asn, Leu, Arg,
Cys, Tyr, Ile, Lys for P3; Cys, Gln, Ala, Ile, Lys, Tyr, for P4 and
Leu, His, Gly, Ser, Arg, Val, Ala, Gln, for P5). Amino acids were
dissolved in DEMEN. After free amino acid treatment, cells were
incubated with 100 ng of each synthetic peptide or allergenic
fractions (Ric c 1 or Ric c 3). Mast cell degranulation was
evaluated as described, and the percentages of degranulation and
histamine release were compared with those triggered by synthetic
peptides or by allergenic isoforms in the absence of free amino acid
treatment.
Quantification of human IgE using ELISA
During the development of this project, there was no contact with
atopic patients. Sera were used after performing security tests, and this
project was not submitted to the human ethics committee because
patients were not identified. Specific IgE levels were tested by ELISA
with 20 mg/well of castor bean allergen. Plates were incubated with
serum from one atopic patient diluted 1:50. Bound IgE antibodies
were detected with biotin-anti-human IgE (1:2000 diluted) followed by
streptavidin-peroxidase conjugate (1:1000 diluted) (Pharmingen). The
peroxidase reaction was developed and the optical density (OD) was
measured at 492 nm. Each value represents the mean of two assays.
OD Values ,0.1 were considered negative.
ELISA inhibition and mast cell activation assay for
analysis of glutamic acid as an IgE blocker
The ability of glutamic acid to inhibit the binding of allergic
patients’ IgE to Ric c 1 and Ric c 3 was assessed by ELISA inhibition
and mast cell activation assays. Briefly, serum from an atopic patient
(427 KU/L- 1:5 diluted) and Wistar rats were preincubated for 1 h
with glutamic acid (end concentration 10 mg/mL). The ELISA or
mast cell degranulation assays were performed as previously
described. The percentage of IgE binding inhibition achieved by
the pre-incubation treatment was calculated as follows: percentage of
IgE binding =100–(ODI/ODT X 100); ODI represents the
absorbance after incubation of glutamic acid-treated human serum;
and ODT represents the absorbance of untreated human sera. Mast
cell granulation or degranulation was counted by optical microscopy
and histamine release was quantified as described above.
Results
Fractionation of serum immunoglobulins by affinity
chromatography
Initially, the serum immunoglobulins (IgG and IgE) were
separated by affinity chromatography. Two fractions denoted FE
Table 1. Identification of IgE epitopes from Ric c 1 and Ric c 3.
Sample/Amino acid
sequences of the peptide
Degranulationin the
presence of total serum
Degranulation in the
presence of IgE (affinity FE)
Degranulation in the
presence of IgG (affinity FG)
Mast cell isolation
(negative control)
30 (+1,0) 30 (+1,0) 30 (+1,0)
2S albumin
(positive control)
70 (+1,0) 78,0 (+1,6) 38,8 (+1,7)
P0/EGLRQAIEQQQSQGQ 74 (+0,9) 75,0 (+0,5) 33,1 (+1,8)
P1/ESKGEREGSSSQQCR 64 (+0,4) 69,9 (+1,7) 38,4 (+0,1)
P2/QEVQRKDLSSCERYL 70 (+0,5) 67,9 (+1,1) 39,0 (+0,7)
P3/QEQQNLRQCQEYIK 65 (+0,7) 65,7 (+0,3) 39,7 (+0,3)
P4/DECQCEAIKYIAEDQ 67 (+0,5) 67,2 (+0,6) 38,4 (+0,9)
P5/LHGEESERVAQRAGE 54 (+0,2) 64,4 (+0,6) 36,0 (+0,8)
doi:10.1371/journal.pone.0021455.t001
Figure 1. Analysis of rat affinity chromatography fractions FE
and FG by dot blotting using a rabbit anti-rat IgG- HRP
conjugate. A1 and B1) negative controls: water plus rat serum anti-2S
albumin; A2 and B2) positive controls: 2S albumin plus rat serum anti-2S
albumin; A3 and B3) affinity buffer plus anti-rat IgG; A4) 2S albumin
incubated with FE plus anti-rat IgG; B4) 2S albumin incubated with FG
plus anti-rat IgG.
doi:10.1371/journal.pone.0021455.g001
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the presence of IgG was investigated in both fractions by dot
blotting. Figure 1 shows the lack of IgG in the supernatant fraction
FE (spot A4), while IgG was detected in eluted fraction (spot B4),
confirming that this immunoglobulin was removed by affinity
chromatography. The supernatant fraction FE was used during
mast cell degranulation assays.
The synthetic peptides present in Ric c 1 and Ric c 3 structures,
which were recognized by the pool of sera and induced mast cell
degranulation as described by Felix et al. [12], were tested in the
presence of the FG or FE fractions. Table 1 shows the sequences of
these peptides and indicates that mast cell degranulation is
mediated only by IgE. The values of mast cell degranulation in the
presence of total serum or FE fractions were similar, ranging from
64 to 78%, whereas degranulation mediated by FG was
disregarded as it was similar to the negative control (approximately
30%).
Importance of carboxylic groups in IgE binding
We found that the peptides identified as IgE epitopes had at
least two glutamic acid residues (Table 1, residues marked in bold).
To verify that these residues are essential for IgE binding, we
examined mast cells incubated with IgE in the presence of
synthetic peptides modified by Woodward’s Reagent K. The first
step of the reaction with WRK is the formation of an irreversible
ketoketenimine that can be identified by a peak of absorbance at
340 nm [14]. The modification of the synthetic peptides by the
WRK reagent was confirmed by specific spectra and by the
increase of the peptide molecular weights by 254 Dalton or
multiples of this value, indicating the inclusion of at least one N-
ethyl-5-phenylisoxazolium-39-sulfonate group (data not shown) by
each glutamic residue. WRK-modified peptides were employed in
mast cell degranulation assays and the results are shown in Table 2.
After WRK treatment, peptide-induced mast cell degranulation
was severely reduced to levels (30–39%) similar to that observed
for the negative controls (30–39%). These data indicate the
importance of carboxylic groups on IgE binding and in the mast
cell degranulation.
Dicarboxylic amino acids inhibit mast cell degranulation
Mast cells preloaded with IgE from rat serum were pre-
incubated with free amino acids and exposed to a 2S albumin pool
or IgE epitopes (synthetic peptides). The rationale of our
experiment is illustrated in Figure S1.
The process of isolation of mast cells from rat peritoneal cavities
induces ,30% degranulation and 2% histamine release; thus, these
values were set as a baseline for the negative controls. Castor bean 2S
albumin induced 70% mast cell degranulation and more than 40%
histamine release when incubated in the presence of IgE (Table 3).
When mast cells were incubated with untreated serum or with
serum treated with neutral or basic amino acids, degranulation
triggered by allergens could be observed (Table 3, column 4).
However, dicarboxylic amino acids protected IgE-bound mast
cells from degranulation as described in Table 3 columns 5 to 7,
implying that binding of IgE to castor bean 2S albumin was
specifically blocked by glutamic or aspartic acid.
Glutamic acid inhibits IgE binding to castor bean allergens.
Initially, the presence of anti-2S albumin IgE specific for castor
bean allergen in sera from five atopic patients was evaluated by dot
blotting, and the results are presented on Table 4. The serum from
patient number 3 (total IgE- 427 KU/L) was the most positive for
2S albumin IgE and was selected for further study. This serum was
fractionated by affinity chromatography and the presence of IgE
was confirmed by dot blotting analysis to be only in the FE
supernatant fraction as presented in Figure 2 (spot 3). We also used
ELISA to examine the binding of this atopic patient serum to the
2S albumin pool and their isolated light and heavy chains and
synthetic peptides P0 to P5. Higher affinity was observed for the
Table 2. Percent of mast cell degranulation induced by
Ricinus communis-derived synthetic peptides.
Peptide
number





Control cells 30633 0 63
P0 74643 7 61
P1 62623 7 62
P2v 65643 0 61
P3 63623 3 62
P4 65643 7 61
P5 53623 9 61
doi:10.1371/journal.pone.0021455.t002
Table 3. Critical role of dicarboxylic amino acid in mast cell degranulation induced by 2S albumin: percent of mast cell
degranulation in the presence of the total serum that had been incubated with or without pooled amino acids.
Sample/Degranulation













the presence of total
serum incubated
with Glu
% of Histamine released
after incubation with Glu
30 (+1.0 ) (negative control) 2 30.0 (61.0) 30.0 (61.0) 30.0 (61.0) 2
70 (+1.0) (Positive control) 64 69.5 (60.5) 36.8 (6.47) 29.7 (60.1) 6
P0/74(+0.9) 80 63.0 (60.7) 40.6 (60.6) 37.6 (60.6) 52
P1/64(+0.4) 58 67.1 (60.7) 39.6 (61.8) 37.0 (61.9) 6
P2/70(+0.5) 64 63.5 (60.4) 40.4 (60.4) 30.3 (61.6) 12
P3/65 +0.7) 58 65.2 (60.7) 40.3 (60.2) 33.8 (61.7) 4
P4/67(+0.5) 60 63.8 (60.8) 39.2 (60.2) 36.7 (60.6) 8
P5/54 +0.2) 56 63.4 (60.9) 41.5 (60.3) 38.8 (61.4) 4
doi:10.1371/journal.pone.0021455.t003
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however, binding was also observed for all tested samples.
The possible blocking effect of glutamic acid was evaluated by
ELISA experiments with serum from an allergic patient, and the
results are presented in Figure 3. Pre-incubation of serum with
glutamic acid inhibited by 78% the IgE binding when 2S albumin
pool or Ric c 1 light chain was tested and inhibited by 56% when
Ric c 1 heavy chain or both chains from Ric c 3 were used. The IgE
binding to P0 and P1 were inhibited by 70% and was completely
inhibited tootherIgEepitopes, P2, P4andP5(Figure3),confirming
the results obtained with sensitized mast cells (Table 3).
Cross-reactivity between castor bean 2S albumin and
airborne/food allergens
The results obtained with mast cells previously sensitized with
castor bean allergens and triggered by cross-reactivity with
commercial allergens are shown in Table 5. Considering positive
reactions to be above 50% degranulation, significant IgE reactivity
to food extracts from shrimp, fish, gluten, wheat, soybean and
peanut were observed. Cross-reactivity was also observed with
inhalable allergens as house dust, tobacco and airborne fungus
(Table 5). Mast cell degranulation for other foods tested as
strawberry, birds, beef, pork, egg white, egg yolk, tomato, milk,
rice, pineapple, cocoa, cashew, orange and lemon and for other
aeroallergens as mites, wool, grass-plot, flowers, cat dander, dog
epithelium, equine epithelium, bovine epithelium, mixed epithe-
lium, feather mix, cotton, mane, grass, silk, flax, cockroach and
cattail were below 35% (data not shown).
Glutamic acid protects against cross-reactivity
As observed in Table 5 (columns 4 and 5), pre-absorption of
serum with glutamic acid resulted in inhibition of IgE reactivity to
both inhalable and food allergens, indicating that the carboxyl
group of these amino acids could be important in IgE-epitope
interactions.
Discussion
The use of castor bean oil in biodiesel production will result in
the increased planting of castor beans. Castor bean allergens are
present not only in the seeds but also in the pollen of this plant
[5,15]. Thus, identifying the allergenic epitopes and reactive
amino acids are critical steps toward the development of strategies
to reduce IgE binding, which will undoubtedly help protect rural
workers or those in direct contact with the seeds.
To determine which amino acids are involved in IgE binding,
the chemical modification of synthetic peptides by WRK was
employed. Yost and Anderson [16] suggested the importance of a
carboxyl group in the NAD-glycohydrolase activity of a Bungarus
fasciatus venom protein as this enzyme is rapidly inactivated by
WRK treatment. To confirm the importance of carboxylic groups
in IgE binding, we have performed blocking assays using free
amino acids (glutamic and aspartic acids) (Table 3). The
dicarboxylic amino acids protected mast cell activation by IgE
from degranulation when these cells were incubated with 2S
albumin or an IgE epitope (synthetic peptides). Here we provided
the first experimental evidence supporting the fundamental role of
amino acids with side chains containing acidic groups (mainly
Table 4. Detection of IgE anti 2S albumin in Human serum by
dot blotting.
Patient SerumTotal IgE (KU/L) Dot Blotting
Control cells 1527 -
12 6 6 +
24 2 7 +++
3 143 -
4 108 -
51 5 2 7 -
doi:10.1371/journal.pone.0021455.t004
Figure 2. Analysis of human serum and affinity chromatogra-
phy fractions, FE and FG by dot blotting using anti-human
biotin IgE/streptavidin-biotinylated-HRP. A1) negative control:
buffer plus human (patient 3) total serum; A2) 2S albumin plus human
(patient 3) total serum; A3) 2S albumin incubated with affinity
chromatography fraction, FE; A4) 2S albumin incubated with affinity
chromatography fraction, FG.
doi:10.1371/journal.pone.0021455.g002
Figure 3. Glutamic acid reduces human IgE binding. ELISA
binding assays of 2S albumin pool, 2S albumin light chain (L), heavy
chain (H) and synthetic peptides with IgE from human serum without
treatment (1) and with human serum treated with glutamic acid (2).
Mean values from 5 experiments 6 SD are presented. Statistical analysis
was performed using one-way ANOVA followed by Turkey’s post-test.
*p ,0.001.
doi:10.1371/journal.pone.0021455.g003
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allergens. Worldwide, 10–20 million people suffer from pollen
allergies [17,18]. Vieths et al. [19] have indicated that between 50%
and 93% of birch pollen allergic individuals develop hypersensitivity
reactions towards certain foods (e.g., apples, carrots, hazelnut, celery),
which is mediated by cross-reactive IgE antibodies primarily directed
against Bet v 1, a major birch pollen allergen [18,19]. This type of
hypersensitivity was described as pollen-food syndrome (PFS) [18,20].
The identification of aeroallergens and food allergens that cross-react
with castor bean is an important step towards developing strategies
for the prevention and treatment of allergies triggered by these
components. The cross-reactivity between castor bean 2S albumin
and allergens from shrimp, fish, wheat, soybean, peanut and corn
causes concern because individuals who live in regions close to castor
bean farmscouldbecomesensitive to these foods. The involvement of
charged amino acids in Blo t 5, the most prevalent Blomia tropicalis
allergen, with IgE binding was observed in another study [21]. These
authors have demonstrated that four charged residues: Glu76, Asp81,
Glu86, and Glu91 (peptide ELKRTDLNILERFNYE), localized to
the region connecting the alpha helices 2 and 3, have been found to
be involved in IgE binding. The pre-absorption of the serum of atopic
individuals with glutamic acid decreased IgE binding to R. communis
allergens (Table 3). We note that this amino acid also affected mast
celldegranulation and histamine release, not onlytriggered by Ric c 1
and Ric c 3, but also triggered by other allergens that showed cross-
r e a c t i v i t yw i t hR i cc1a n dR i cc3 .T h e r ei sc o n t i n u i n gc o n c e r nw i t h
the development of new drugs for the treatment of allergy and allergic
rhinitis. A list of the medications used in allergic rhinitis, including
their mechanisms of action and side effects, was presented by two
other studies [22,23]. The results presented in this manuscript
support a new strategy for drug development based on IgE blocking
(Machado et al., Brazilian patent 00320/2005) [24].
Supporting Information
Figure S1 (A) Hypersensitivity reactions: a) Allergenic proteins
are processed by antigen-presenting cells (APC) by the MHC class
II pathway with subsequent increases in IgE production; b) IgE
sensitizes mast cells by binding to FceRI; c) A second exposure to
the allergen activates these cells to degranulate and release
vasoactive amines. (B) Blockage of IgE: a) Sensitized mast cells are
incubated with glutamic or aspartic acid; b) These dicarboxylic
amino acids bind to IgE-sensitized mast cells resulting in
protection from mast cell degranulation.
(TIF)
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